Cargando...
A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy
PURPOSE: Doxorubicin (DOX) is a very effective anticancer agent. However, in its pure form, its application is limited by significant cardiotoxic side effects. The purpose of this study was to develop a controllably activatable chemotherapy prodrug of DOX created by blocking its free amine group wit...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2916115/ https://ncbi.nlm.nih.gov/pubmed/20596761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-010-0183-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|